Multiple Myeloma Among Topics in APSHO Educational Series for Healthcare Workers

Multiple Myeloma Among Topics in APSHO Educational Series for Healthcare Workers
0
(0)

The Advanced Practitioners Society for Hematology and Oncology (APSHO) is presenting a series of live continuing medical education (CME) meetings, titled the “APSHO Regional Lecture Series.” The accredited meetings are designed for nurses, physician assistants, clinical nurse specialists, advanced degree nurse pharmacists, and others involved in caring for patients with multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and non-small cell lung cancer (NSCLC).

Two of 2016’s lectures focusing on multiple myeloma (MM) have already taken place (April 9 in Memphis, Tennessee, and on June 11 in New Brunswick, New Jersey). Upcoming sessions, with links to their agenda and for registration purposes, are on these dates and take place at the following locations:

Each session is a source of continuing education credits. According to a press release, after one of these programs, a participant should be able to:

  • Demonstrate a general understanding of how to perform a bone marrow biopsy
  • Describe the various mechanisms of action of the agents used to treat multiple myeloma
  • Apply the principles of risk-adapted treatment, using case-based scenarios to illustrate the impact of patient attributes and disease-specific attributes
  • Manage toxicities associated with newer treatment agents
  • Apply the principles of adjunctive supportive care in the treatment of multiple myeloma patients

APSHO was established to improve the quality of care for cancer patients by addressing key issues in education and clinical and professional development for advanced practitioners working in hematology and oncology. The organization is led by nurses, physicians and pharmacists, among other clinical professionals, who focus on a collaborative approach in patient care.

Co-chairs for this series are Sandra E. Kurtin, RN, MS, AOCN, ANP-C, a clinical assistant professor of Medicine and adjunct clinical assistant professor of Nursing at the University of Arizona Cancer Center, in Tucson; and Beth Eaby-Sandy, MSN, CRNP, OCN, a nurse practitioner at the University of Pennsylvania’s Abramson Cancer Center, in Philadelphia.

Registration is required, and can be done by clicking on a session’s link.

 

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • Blenrep approved
  • COVID-19 case report
  • trial of myeloma drug Aplidin for COVID-19
  • MOR202

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?